IMMU-02. VALIDATION OF PD-L1 EXPRESSION IN HIGH GRADE GLIOMAS AS AN INDEPENDENT NEGATIVE PROGNOSTIC MARKER

INTRODUCTION: Checkpoint inhibition is believed to be a promising method of immune modulation for cancer patients. PD-L1 expression has correlated with improved response to anti-PD-1 therapy in other tumors. However, evaluation of PD-L1 expression in high grade glioma (HGG) patients remains fragment...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Pratt, Drew, Dominah, Gifty, Lobel, Graham, Obungu, Arnold, Wang, Xiang, Edwards, Nancy A, Maric, Dragan, Gilbert, Mark R, Quezado, Martha, Nduom, Edjah K
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692964/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.461
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky